Ensysce Biosciences, Inc. (ENSC) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$10.18M | -27.4% |
| 2024 | -$7.99M | +24.8% |
| 2023 | -$10.63M | +56.1% |
| 2022 | -$24.21M | +16.9% |
| 2021 | -$29.15M | -18017.1% |
| 2020 | -$160.9K | +84.9% |
| 2019 | -$1.07M | -152.0% |
| 2018 | $2.05M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$10.18M | -27.4% |
| 2024 | -$7.99M | +24.8% |
| 2023 | -$10.63M | +56.1% |
| 2022 | -$24.21M | +16.9% |
| 2021 | -$29.15M | -18017.1% |
| 2020 | -$160.9K | +84.9% |
| 2019 | -$1.07M | -152.0% |
| 2018 | $2.05M | — |